40 Stocks Moving In Friday's Mid-Day Session Gainers Turning Point Therapeutics, Inc. (NASDAQ: TPTX) shares jumped 115.8% to $73.72 after Bristol Myers Squibb announced it will acquire Turning Point Therapeutics for $76 per share. Benzinga · Jun 3, 2022
Why Zosano Pharma Shares Are Getting Hammered Today Zosano Pharma Corp (NASDAQ: ZSAN) shares are trading lower by 44.35% at $0.98 after the company announced it filed a voluntary petition for relief under chapter 11. Benzinga · Jun 2, 2022
Zosano Pharma: Q1 Earnings Insights Zosano Pharma (NASDAQ:ZSAN) reported its Q1 earnings results on Friday, May 13, 2022 at 04:00 PM. Here's what investors need to know about the announcement. Earnings Zosano Pharma reported in-line EPS of $-1.75 versus an estimate of $-1.75. Benzinga · May 13, 2022
Zosano Pharma's Return On Capital Employed Insights According to data from Benzinga Pro, during Q4, Zosano Pharma's (NASDAQ:ZSAN) reported sales totaled $87.00 thousand. Despite a 19.58% increase in earnings, the company posted a loss of $6.97 million. Benzinga · May 9, 2022
12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Zosano Pharma (NASDAQ:ZSAN) shares rose 3127.9% to $3.88 during Tuesday's pre-market session. The market value of their outstanding shares is at $19.0 million. Benzinga · Apr 12, 2022
Zosano Lays Off ~30% Of Its Workforce After FDA Rejection Of Migraine Drug Application Zosano Pharma Corp (NASDAQ: ZSAN) is looking at strategic alternatives and Benzinga · Mar 18, 2022
Looking Into Zosano Pharma's Return On Capital Employed According to data from Benzinga Pro, during Q4, Zosano Pharma's (NASDAQ:ZSAN) reported sales totaled $87.00 thousand. Despite a 19.58% increase in earnings, the company posted a loss of $6.97 million. Benzinga · Mar 18, 2022
FDA Rejects Zosano Pharma's Application For Zolmitriptan Microneedle System Again, Shares Plunge The FDA has issued a response letter to Zosano Pharma Corp (NASDAQ: Benzinga · Feb 22, 2022